New users of antidepressant medications: First episode duration and predictors of discontinuation

European Journal of Clinical Pharmacology

Volumn 68, Issue 1, 2012, Pages 65-71

  Lu, Christine Y ^a   Roughead, Elizabeth ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Antidepressant; Determinants; Mental health; Persistence

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CANCER PATIENT; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MENTAL HEALTH SERVICE; MENTAL PATIENT; MORBIDITY; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SOCIAL STATUS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VETERAN;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; AUSTRALIA; COHORT STUDIES; COMORBIDITY; DEMENTIA; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; VETERANS HEALTH;

EID: 84857057038     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1087-3     Document Type: Article

References (29)

1. S Moussavi S Chatterji E Verdes A Tandon V Patel B Ustun 2007 Depression, chronic diseases, and decrements in health: results from the World Health Surveys Lancet 370 9590 851 858 17826170 10.1016/S0140-6736(07)61415-9 (Pubitemid 47362344)
2. Australian Bureau of Statistics (2008) National Survey of Mental Health and Wellbeing: summary of results. http://www.abs.gov.au. Accessed 18 October 2010
3. DM Clarke KC Currie 2009 Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence Med J Aust 190 7 Suppl S54 S60 19351294
4. M Prince V Patel S Saxena M Maj J Maselko MR Phillips A Rahman 2007 No health without mental health Lancet 370 9590 859 877 17804063 10.1016/S0140-6736(07)61238-0 (Pubitemid 47371145)
5. UK National Institute for Health and Clinical Excellence (2009) Depression in adults with a chronic physical health problem: treatment and management (clinical guideline 91). NIHCE, London
6. UK National Institute for Health and Clinical Excellence (2009) Depression: the treatment and management of depression in adults (clinical guideline 90). NIHCE, London
7. PM Ellis DA Smith 2002 Treating depression: the beyondblue guidelines for treating depression in primary care. "Not so much what you do but that you keep doing it" Med J Aust 176 Suppl S77 S83 12065002
8. JR Geddes SM Carney C Davies TA Furukawa DJ Kupfer E Frank GM Goodwin 2003 Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 9358 653 661 12606176 10.1016/S0140-6736(03)12599-8 1:CAS:528:DC%2BD3sXhsVajt7g%3D (Pubitemid 36246547)
9. CY Lu J Barratt A Vitry E Roughead 2011 Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting J Clin Epidemiol 64 2 223 228 21172602 10.1016/j.jclinepi.2010.02.015
10. E Roughead E Ramsay K Priess J Barratt P Ryan AL Gilbert 2009 Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates Pharmacoepidemiol Drug Saf 18 1 69 75 10.1002/pds.1687 19111013 10.1002/pds.1687
11. World Health Organization Collaborating Centre for Drug Statistics Methodology (2011) International language for drug utilization research. Available from: www.whocc.no/. Accessed Feb 01, 2010
12. Australian Government Department of Health and Ageing (2009) Schedule of pharmaceutical benefits. http://www.pbs.gov.au/. Accessed Feb 01, 2010
13. Australian Government Department of Health and Ageing (2009) Medicare benefits schedule. http://www.health.gov.au/internet/mbsonline/publishing.nsf/ Content/Medicare-Benefits-Schedule-MBS-1. Accessed Feb 01, 2010
14. Australian Government Department of Veterans' Affairs (2008) Australian veterans and war widows. Your lives, your needs, 5th ed. DVA, Canberra
15. Australian Government Department of Veterans' Affairs (2010) Treatment population statistics. Quarterly report-June 2010. http://www.dva.gov.au/ aboutDVA/Statistics/Pages/Statistics.aspx#treat. Accessed May 03, 2011
16. P McManus A Mant P Mitchell H Britt J Dudley 2003 Use of antidepressants by general practitioners and psychiatrists in Australia Aust N Z J Psychiatry 37 2 184 189 12656957 10.1046/j.1440-1614.2003.01132.x (Pubitemid 36592728)
17. N Donnelly P McManus J Dudley W Hall 2000 Impact of increasing the re-supply interval on the seasonality of subsidised prescription use in Australia Aust N Z J Public Health 24 6 603 606 11215008 10.1111/j.1467-842X. 2000.tb00524.x 1:STN:280:DC%2BD3M7kt1aitA%3D%3D (Pubitemid 32094236)
18. Australian Bureau of Statistics (2008) SEIFA: socio-economic indexes for areas 2006. http://www.abs.gov.au. Accessed Aug 18, 2010
19. H Quan V Sundararajan P Halfon A Fong B Burnand JC Luthi LD Saunders CA Beck TE Feasby WA Ghali 2005 Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 11 1130 1139 16224307 10.1097/01.mlr.0000182534.19832.83 (Pubitemid 41587600)
20. KL Sloan AE Sales CF Liu P Fishman P Nichol NT Suzuki ND Sharp 2003 Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument Med Care 41 6 761 774 10.1097/01.MLR.0000064641.84967.B7 12773842
21. ML Johnson HB El-Serag TT Tran C Hartman P Richardson NS Abraham 2006 Adapting the Rx-Risk-V for mortality prediction in outpatient populations Med Care 44 8 793 797 16862043 10.1097/01.mlr.0000218804.41758.ef (Pubitemid 44284272)
22. P McManus A Mant P Mitchell J Dudley 2004 Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia Aust N Z J Psychiatry 38 6 450 454 15209838 10.1080/j.1440-1614.2004. 01383.x (Pubitemid 39029053)
23. K Demyttenaere P Enzlin W Dewe B Boulanger J De Bie W De Troyer P Mesters 2001 Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events J Clin Psychiatry 62 Suppl 22 30 33 11599645 1:CAS:528:DC%2BD3MXotVemu7c%3D (Pubitemid 32937583)
24. VM Hunot R Horne MN Leese RC Churchill 2007 A cohort study of adherence to antidepressants in primary care: The influence of antidepressant concerns and treatment preferences Prim Care Companion J Clin Psychiatry 9 2 91 99 17607330 10.4088/PCC.v09n0202 (Pubitemid 46607462)
25. DG Hansen W Vach JU Rosholm J Sondergaard LF Gram J Kragstrup 2004 Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics Fam Pract 21 6 623 629 15520034 10.1093/fampra/cmh608 (Pubitemid 39654859)
26. P McManus A Mant PB Mitchell WS Montgomery J Marley ME Auland 2000 Recent trends in the use of antidepressant drugs in Australia, 1990-1998 Med J Aust 173 9 458 461 11149300 1:STN:280:DC%2BD3M7htlCrsw%3D%3D
27. UK National Institute for Health and Clinical Excellence (2007) Management of anxiety (panic disorder, with or without agoraphobia and generalised anxiety disorder) in adults in primary, secondary and community care (clinical guideline 22 amended). NIHCE, London
28. SA Hollingworth PM Burgess HA Whiteford 2010 Affective and anxiety disorders: prevalence, treatment and antidepressant medication use Aust N Z J Psychiatry 44 6 513 519 10.3109/00048670903555138 20482411
29. A Gichangi M Andersen J Kragstrup W Vach 2006 Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice Pharmacoepidemiol Drug Saf 15 3 167 177 10.1002/pds.1160 16315340 10.1002/pds.1160